Business
Global Phase 3 Trial of Presendin to Launch in Q4 2021
Global Phase 3 Trial of Presendin to Launch in Q4 2021
About this update from Invex Therapeutics Ltd.
[{"type":"text","content":"Invex Therapeutics Ltd has released a press release. View Attachment","length":243,"tagName":"div"}]